Worse results seen after PCI in diabetes patients with STEMI

12/27/2011 | Medscape (free registration)

Diabetes patients who had percutaneous stenting for ST-segment elevation myocardial infarction appeared to face a greater risk of heart attack, target lesion revascularization and all-cause mortality than those without diabetes who had the procedure, a study in the American Journal of Cardiology found.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC